Last updated on November 2017

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia (BPH)


Brief description of study

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia (BPH)

Detailed Study Description

Receive Redovapagon or Placebo for the treatment of nocturia

Clinical Study Identifier: TX81985

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Carlos Colunga, CRC

Clinical Research of South Florida
Coral Gables, FL USA
  Connect »